Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Abstract Therapeutic protocols including EGFR antibodies in the context of oxaliplatin-based regimens have variable clinical effect in colorectal cancer. Here, we tested the effect of the EGFR antibody cetuximab in different sequential combinations with oxaliplatin on the growth of colorectal cancer...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elli Narvi, Katri Vaparanta, Anna Karrila, Deepankar Chakroborty, Sakari Knuutila, Arto Pulliainen, Maria Sundvall, Klaus Elenius
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/6509ba9e46f9450ab57d53a05d5f7f52
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!